中文
English
한국어
日本語
Español
Français
Русский
| カタログ番号 | HW527014 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 種反応性 | Human, Rat | ||||||||
| アプリケーション | ELISA, IHC, WB | ||||||||
| 宿主種 | Rabbit | ||||||||
| クローン性 | Polyclonal | ||||||||
| アイソタイプ | IgG | ||||||||
| 免疫原 | E. coli - derived recombinant Human VHL (Glu70-Asp213). | ||||||||
| ターゲット | VHL, pVHL, Protein G7, von Hippel-Lindau disease tumor suppressor | ||||||||
| 精製 | Purified by antigen affinity column. | ||||||||
| アクセッション番号 | P40337 | ||||||||
| 形態 | Liquid | ||||||||
| 保存バッファー | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。 |
||||||||
| 製品使用情報 |
| ||||||||
| 安定性と保存 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. | ||||||||
| 背景 | von Hippel-Lindau disease tumor suppressor (VHL) is a ~24 kDa protein. Involved in the ubiquitination and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Seems to act as a target recruitment subunit in the E3 ubiquitin ligase complex and recruits hydroxylated hypoxia-inducible factor (HIF) under normoxic conditions. Involved in transcriptional repression through interaction with HIF1A, HIF1AN and histone deacetylases. Ubiquitinates, in an oxygen-responsive manner, ADRB2. Acts as a negative regulator of mTORC1 by promoting ubiquitination and degradation of RPTOR. 1. Tanimoto, K. et al. (2000) The EMBO journal 19, 4298-309. PMID: 10944113 2. Cheng, J. et al. (2007) Cell 131, 584-95. PMID: 17981124 3. Xie, L. et al. (2009) Science signaling 2, ra33. PMID: 19584355 4. Ganner, A. et al. (2021) Scientific reports 11, 14827. PMID: 34290272 | ||||||||
| 注意事項 | For research use only. |
+86-027-65523339
中国武漢市深敦寺路666号C棟、武漢、430206
